Shartsis Friese brings industry insights and experience to complex transactions within the healthcare and life sciences markets.
Firm attorneys advise a broad range of public and private healthcare clients on corporate and securities matters, although not on specific issues of healthcare regulatory law. Our clients include life sciences, medical device, and management service organizations, and our clients have progressed from being startups or early stage to being public companies.
Our advice has ranged from initial and subsequent rounds of financing to corporate governance to preparation for IPO to mergers and acquisitions, including reversing into public companies and De-SPAC.
